Results 31 to 40 of about 2,262 (235)

Design of the Optimal Trial of Combination Therapy

open access: yesFrontiers in Endocrinology, 2020
Patients who take levothyroxine monotherapy to treat hypothyroidism frequently experience residual symptoms despite TSH testing at target levels. Trials have been conducted to evaluate the potential benefit of combination therapy with levothyroxine and ...
Anne R. Cappola
doaj   +1 more source

Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study.

open access: yesJ Clin Endocrinol Metab
Context: Autoimmune hypothyroidism is a common endocrine disorder affecting 1% to 2% of the population in iodine sufficient areas. While levothyroxine is standard treatment, a substantial number of patients report persistent symptoms despite adequate ...
Hedberg F   +7 more
europepmc   +2 more sources

Effect of Liothyronine Treatment on Dermal Temperature and Activation of Brown Adipose Tissue in Female Hypothyroid Patients: A Randomized Crossover Study

open access: yesFrontiers in Endocrinology, 2021
BackgroundThyroid hormones are essential for the full thermogenic response of brown adipose tissue (BAT) and have been implicated in dermal temperature regulation.
Betty Ann Bjerkreim   +17 more
doaj   +1 more source

The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial [PDF]

open access: yesInternational Archives of Health Sciences
Objectives: This study aimed to assess the effects of Liothyronine supplementation on memory performance in patients diagnosed with mood disorders (major depressive or bipolar disorder).Methods: This double-blind controlled clinical trial was conducted ...
Pooya Hazegh   +3 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011–2020 [PDF]

open access: yes, 2020
From Wiley via Jisc Publications RouterHistory: received 2020-11-08, rev-recd 2020-12-14, accepted 2020-12-21, pub-electronic 2021-03-21, pub-print 2021-06Article version: VoRPublication status: PublishedAbstract: Introduction: Recent prescribing ...
Premawardhana, Lakdasa; orcid:   +5 more
core   +1 more source

Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design

open access: yesFrontiers in Endocrinology, 2020
Hypothyroidism is a common condition with a wide spectrum of etiologies and clinical manifestations. While the majority of patients affected by hypothyroidism respond well to levothyroxine, some patients do not and complain of symptoms despite adequate ...
Ritu Madan, Francesco S. Celi
doaj   +1 more source

Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine [PDF]

open access: yes, 2005
9 pages, 3 figures, 4 tables.-- Review.CONTEXT: Combined infusion of levothyroxine plus liothyronine, as opposed to levothyroxine alone, is the only way of restoring the concentrations of circulating TSH, T4, and T3 as well as those of both T4 and T3 in ...
Morreale de Escobar, Gabriella   +3 more
core   +1 more source

Case Report: Myxedema Coma Caused by Immunoglobulin A Vasculitis in a Patient With Severe Hypothyroidism

open access: yesFrontiers in Immunology, 2022
Myxedema coma is a critical disorder with high mortality rates. Disruption of the compensatory mechanism for severe and long-term hypothyroidism by various causes leads to critical conditions, including hypothermia, respiratory failure, circulatory ...
Hiroshi Ito   +15 more
doaj   +1 more source

Use of combined liothyronine and thyroxine therapy for consumptive hypothyroidism associated with hepatic haemangiomas in infancy [PDF]

open access: yes, 2010
Hepatic haemiangiomas in infancy are rare. An association with hypothyroidism has been previously reported and is believed to be secondary to the conversion of thyroxine (fT4) to biologically inactive reverse triiodothyronine (rT3) by type 3 ...
Catherine Peters   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy